JP6250353B2 - Containerized green tea beverage containing quercetin glycoside - Google Patents
Containerized green tea beverage containing quercetin glycoside Download PDFInfo
- Publication number
- JP6250353B2 JP6250353B2 JP2013205891A JP2013205891A JP6250353B2 JP 6250353 B2 JP6250353 B2 JP 6250353B2 JP 2013205891 A JP2013205891 A JP 2013205891A JP 2013205891 A JP2013205891 A JP 2013205891A JP 6250353 B2 JP6250353 B2 JP 6250353B2
- Authority
- JP
- Japan
- Prior art keywords
- tea
- quercetin
- quercetin glycoside
- glycoside
- green tea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- REFJWTPEDVJJIY-UHFFFAOYSA-N quercetin Natural products C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 title claims description 97
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 title claims description 78
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 title claims description 78
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 title claims description 78
- 235000005875 quercetin Nutrition 0.000 title claims description 78
- 229960001285 quercetin Drugs 0.000 title claims description 78
- 244000269722 Thea sinensis Species 0.000 title claims description 73
- 229930182470 glycoside Natural products 0.000 title claims description 65
- -1 quercetin glycoside Chemical class 0.000 title claims description 60
- 235000013361 beverage Nutrition 0.000 title claims description 31
- 235000009569 green tea Nutrition 0.000 title claims description 25
- 235000013616 tea Nutrition 0.000 claims description 50
- 238000000034 method Methods 0.000 claims description 34
- 230000001954 sterilising effect Effects 0.000 claims description 18
- 235000000346 sugar Nutrition 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 229940092665 tea leaf extract Drugs 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims 2
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 39
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 39
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 38
- QJTYCCFDQWFJHU-UHFFFAOYSA-N Quercetin-5-O-beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC2=C1C(=O)C(O)=C(C=1C=C(O)C(O)=CC=1)O2 QJTYCCFDQWFJHU-UHFFFAOYSA-N 0.000 description 30
- SZDMSNWMQAMVTJ-UHFFFAOYSA-N quercetin-3-O-glucoside Natural products OC1OC(COC2=C(C(=O)c3cc(O)cc(O)c3O2)c4ccc(O)c(O)c4)C(O)C(O)C1O SZDMSNWMQAMVTJ-UHFFFAOYSA-N 0.000 description 30
- FZKBNCDAGYDHTP-UHFFFAOYSA-N quercetin-3-O-glycoside Natural products OC1C(O)C(O)C(O)OC1COC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O FZKBNCDAGYDHTP-UHFFFAOYSA-N 0.000 description 30
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 20
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 20
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 20
- 229960004555 rutoside Drugs 0.000 description 20
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 19
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 19
- 235000005493 rutin Nutrition 0.000 description 19
- 238000004659 sterilization and disinfection Methods 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 235000001727 glucose Nutrition 0.000 description 12
- 235000019640 taste Nutrition 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 238000011088 calibration curve Methods 0.000 description 5
- 150000002338 glycosides Chemical class 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 240000008620 Fagopyrum esculentum Species 0.000 description 4
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 4
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 102000051366 Glycosyltransferases Human genes 0.000 description 3
- 108700023372 Glycosyltransferases Proteins 0.000 description 3
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000002304 glucoses Chemical class 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 244000291564 Allium cepa Species 0.000 description 2
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 2
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 2
- 244000046101 Sophora japonica Species 0.000 description 2
- 235000010586 Sophora japonica Nutrition 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 235000019225 fermented tea Nutrition 0.000 description 2
- 235000020688 green tea extract Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 2
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 2
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical group N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000024883 vasodilation Effects 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 241000873224 Capparaceae Species 0.000 description 1
- 235000017336 Capparis spinosa Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 244000141359 Malus pumila Species 0.000 description 1
- 206010050661 Platelet aggregation inhibition Diseases 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 238000010793 Steam injection (oil industry) Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 244000078534 Vaccinium myrtillus Species 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000021019 cranberries Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- GVYLCNUFSHDAAW-UHFFFAOYSA-N mirex Chemical compound ClC12C(Cl)(Cl)C3(Cl)C4(Cl)C1(Cl)C1(Cl)C2(Cl)C3(Cl)C4(Cl)C1(Cl)Cl GVYLCNUFSHDAAW-UHFFFAOYSA-N 0.000 description 1
- 108010001078 naringinase Proteins 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- VVXVTYYCCQZUKK-UHFFFAOYSA-N quercetin 3-rutinoside Natural products CC1OC(OCC2OC(OC3=C(Oc4ccc(O)c(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C(O)C2O)C(O)C(O)C1O VVXVTYYCCQZUKK-UHFFFAOYSA-N 0.000 description 1
- 235000021013 raspberries Nutrition 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Description
本発明は、ケルセチン配糖体を含有する容器詰緑茶飲料に関し、より詳細には、ケルセチン配糖体に起因するエグ味が低減された、ケルセチン配糖体を含有する容器詰緑茶飲料とその製造方法に関する。 The present invention relates to a container-packed green tea beverage containing a quercetin glycoside, and more specifically, a container-packed green tea beverage containing a quercetin glycoside with reduced taste from quercetin glycoside and its production Regarding the method.
ケルセチンは野菜や果物に豊富に含まれるポリフェノール成分であり、そのままで、又は配糖体(ルチン、クエルシトリンなど)の形で、柑橘類、タマネギ、ソバ、エンジュ等の種々の植物に含まれている。
ケルセチンは、強力な抗酸化活性の他、血小板の凝集抑制および接着抑制作用、血管拡張作用、抗ガン作用等、多彩な生理機能をもつことが知られている(非特許文献1)。そして、ケルセチン配糖体に関しては、結合するグルコース数が1、2及び3と増すにつれて、経口吸収性が高くなり、グルコース数(n)が4になると経口吸収性が低下することが分かっている(特許文献1参照)。
ケルセチン配糖体の一つ、ルチンを高含有する飲料として、韃靼そば茶飲料が知られている。ルチンには、特有の生臭さ、苦味及び後味の悪さ(ぬめり)があるために、韃靼そば茶飲料に関しては、風味を改善するための方法が検討されている(特許文献2)。
一方、ケルセチン配糖体を配合した容器詰め茶飲料については、アスコルビン酸含量を抑え、かつさらにpHを調整することでより安定性が相乗効果的に増すとともに、緑茶飲料においては、緑茶本来の豊かな味わいを維持できることが分かっている(特許文献3)。
Quercetin is a polyphenol component that is abundant in vegetables and fruits, and is contained in various plants such as citrus fruits, onions, buckwheat, and enju as it is or in the form of glycosides (rutin, quercitrin, etc.) .
Quercetin is known to have a variety of physiological functions such as platelet aggregation inhibition and adhesion inhibition, vasodilation, and anticancer in addition to strong antioxidant activity (Non-patent Document 1). And for quercetin glycosides, it is known that the oral absorption increases as the number of glucose bound increases to 1, 2 and 3, and the oral absorption decreases when the glucose number (n) reaches 4. (See Patent Document 1).
A soba tea drink is known as a drink containing a high content of rutin, one of quercetin glycosides. Since rutin has a unique raw odor, bitterness and bad aftertaste (slimy), a method for improving the flavor of the buckwheat tea drink has been studied (Patent Document 2).
On the other hand, for tea-packed tea beverages containing quercetin glycosides, the ascorbic acid content is reduced and the pH is adjusted to increase the synergistic effect. It is known that a good taste can be maintained (Patent Document 3).
本発明者らは、ケルセチン配糖体を配合した容器詰緑茶飲料について検討してきた。しかし、緑茶にケルセチン配糖体を配合することで、ケルセチン配糖体由来の粉っぽさが生じ、緑茶本来の良質な香気香味が阻害されるという問題があった。さらに、加熱殺菌や長期保存により、ケルセチン配糖体由来のエグ味が発生することも、問題であった。 The inventors of the present invention have examined a container-packed green tea drink containing quercetin glycoside. However, when quercetin glycoside is added to green tea, there is a problem that a powdery sensation derived from quercetin glycoside is produced, and the original high quality aroma and flavor of green tea is inhibited. In addition, it has been a problem that an egg flavor derived from quercetin glycoside is generated by heat sterilization or long-term storage.
本発明の課題は、ケルセチン配糖体を配合した容器詰緑茶飲料において、ケルセチン配糖体由来の粉っぽさが低減され、緑茶本来の良質な香気香味を有し、加熱殺菌や長期保存にも適した容器詰緑茶飲料を提供することにある。 The problem of the present invention is that in a packaged green tea beverage containing a quercetin glycoside, the powderyness derived from the quercetin glycoside is reduced, and the green tea has an original high-quality aroma and flavor for heat sterilization and long-term storage. It is also in providing a suitable packaged green tea beverage.
本発明者らは、上記課題を解決すべく鋭意検討を行った結果、ケルセチン配糖体を配合した容器詰緑茶飲料において、原料茶葉に焙じ茶を含む茶葉を用いることで、ケルセチン配糖体由来の粉っぽさが低減され、緑茶本来の良質な香気香味を有する容器詰緑茶飲料が得られることを見出した。さらに、本発明者らは、加熱殺菌処理や長期保存により発生する、ケルセチン配糖体の加熱臭であるエグ味の抑制効果が得られることを見出した。 As a result of intensive studies to solve the above-mentioned problems, the present inventors have used a tea leaf containing roasted tea as a raw tea leaf in a container-packed green tea beverage containing quercetin glycoside, which is derived from quercetin glycoside. It has been found that a packaged green tea beverage having reduced powderiness and green tea original high quality aroma flavor can be obtained. Furthermore, the present inventors have found that the effect of suppressing the taste that is a heated odor of quercetin glycosides generated by heat sterilization treatment or long-term storage can be obtained.
すなわち、これに限定されるものではないが、本発明は以下を包含する。
1.(i)〜(iii)の工程を含む、ケルセチン配糖体配合容器詰緑茶飲料の製造方法:
(i)焙じ茶葉を含む茶葉を抽出して、茶葉抽出液を得る工程、
(ii)当該茶葉抽出液にケルセチン配糖体を添加する工程、
(iii)工程(ii)において得られた液を加熱殺菌する工程。
2.原料の茶葉中に含まれる焙じ茶葉の割合が1重量以上%である、1に記載の方法。
3.ケルセチン配糖体の配合量が、100〜500ppmである、1又は2に記載の方法。
4.1〜3に記載の方法によって製造される、容器詰緑茶飲料。
5.(i)〜(iii)の工程を含む、ケルセチン配糖体配合容器詰緑茶飲料の粉っぽさ及びエグ味を抑制する方法:
(i)焙じ茶葉を含む茶葉を抽出して、茶葉抽出液を得る工程、
(ii)当該茶葉抽出液にケルセチン配糖体を添加する工程、
(iii)工程(ii)において得られた液を加熱殺菌する工程。
That is, although not limited to this, this invention includes the following.
1. A process for producing a green tea beverage containing a quercetin glycoside-containing container, comprising the steps (i) to (iii):
(I) extracting tea leaves including roasted tea leaves to obtain a tea leaf extract;
(Ii) adding a quercetin glycoside to the tea leaf extract,
(Iii) A step of heat sterilizing the liquid obtained in step (ii).
2. 2. The method according to 1, wherein the ratio of roasted tea leaves contained in the raw tea leaves is 1% by weight or more.
3. 3. The method according to 1 or 2, wherein the amount of quercetin glycoside is 100 to 500 ppm.
4. A packaged green tea beverage produced by the method described in 4.1-3.
5). A method for suppressing the powdery and sweet taste of a quercetin-glycoside-contained container-packed green tea beverage comprising the steps of (i) to (iii):
(I) extracting tea leaves including roasted tea leaves to obtain a tea leaf extract;
(Ii) adding a quercetin glycoside to the tea leaf extract,
(Iii) A step of heat sterilizing the liquid obtained in step (ii).
本発明によれば、ケルセチン配糖体由来の粉っぽさが低減され、緑茶本来の良質な香気香味を有し、加熱殺菌や長期保存にも適した容器詰緑茶飲料を提供できる。本発明のケルセチン配糖体配合容器詰緑茶飲料は、ケルセチン配糖体由来の異味、すなわち粉っぽさやエグ味がなく、すっきり飲めるため、食事と併せての飲用にも好適である。 ADVANTAGE OF THE INVENTION According to this invention, the powdery origin derived from a quercetin glycoside can be reduced, it can provide the packaged green tea drink which has the original high quality aromatic flavor of green tea, and is suitable also for heat sterilization and long-term storage. The quercetin glycoside-contained container-packed green tea beverage of the present invention has no off-flavor derived from quercetin glycoside, that is, no powdery taste and no taste, and is suitable for drinking with meals.
本発明の飲料は、原料の茶葉に焙じ茶葉を含むことを特徴とする。焙じ茶葉に含まれるピラジン成分の作用により、本発明の飲料中のケルセチン配糖体に由来する粉っぽさや加熱により生じるエグ味を抑制するものと考えられる。ここで、焙じ茶葉とは、飲用に供することが可能な焙じた茶葉をいい、通常、煎茶や番茶、茎茶を180℃以上、好ましくは200℃以上で焙煎した茶葉である。焙じ茶葉は1種でもよく、2種以上を用いてもよい。 The beverage of the present invention is characterized in that the raw tea leaves contain roasted tea leaves. By the action of the pyrazine component contained in the roasted tea leaves, it is considered to suppress the powderyness derived from the quercetin glycoside in the beverage of the present invention and the taste caused by heating. Here, the roasted tea leaves refer to roasted tea leaves that can be used for drinking, and are usually tea leaves obtained by roasting sencha, bancha, and stem tea at 180 ° C or higher, preferably 200 ° C or higher. One type of roasted tea leaves may be used, or two or more types may be used.
本発明で用いる原料茶葉中に含ませる焙じ茶葉の割合は1重量%以上であればよく、1〜40重量%が好ましく、2〜20重量%がより好ましく、5〜15重量%が特に好ましい。焙じ茶葉の割合が1重量%未満であると、本効果は得られない。 The ratio of the roasted tea leaves contained in the raw tea leaves used in the present invention may be 1% by weight or more, preferably 1 to 40% by weight, more preferably 2 to 20% by weight, and particularly preferably 5 to 15% by weight. When the ratio of roasted tea leaves is less than 1% by weight, this effect cannot be obtained.
焙じ茶葉を除く茶葉は、これに限定されるものではないが、例えば、煎茶、深蒸煎茶、玉露、かぶせ茶、番茶、玉緑茶、芽茶、茎茶、棒茶などの中の1種類を単独で用いてもよいし、また、2種類以上の茶葉を組み合わせて用いてもよい。さらに、緑茶などの不発酵茶に加えて、半発酵茶(例えば烏龍茶)、発酵茶(例えば紅茶)等をブレンドすることも可能である。 The tea leaves other than roasted tea leaves are not limited to this, but for example, one kind of sencha, deep steamed sencha, gyokuro, kabusecha, bancha, tamago green tea, bud tea, stem tea, stick tea, etc. Or two or more types of tea leaves may be used in combination. Furthermore, in addition to non-fermented tea such as green tea, semi-fermented tea (for example, oolong tea), fermented tea (for example, black tea) and the like can be blended.
焙じ茶葉を含む茶葉の抽出は、30〜95℃、好ましくは60〜90℃の水を用いて行う。抽出温度が高すぎると、苦渋みが強くなり、抽出液の香味が悪くなり、また、加熱殺菌や長期保存により加熱臭の発生が顕著となる。抽出温度が低すぎると、焙じ茶中のピラジン成分が十分に抽出されず、本効果が得られない可能性がある。抽出時間は、好ましくは1〜30分であり、より好ましくは2〜10分である。茶葉に対する抽出する水の重量比率は、好ましくは5〜500であり、より好ましくは5〜100である。 Extraction of tea leaves including roasted tea leaves is performed using water at 30 to 95 ° C, preferably 60 to 90 ° C. If the extraction temperature is too high, the bitterness becomes stronger, the flavor of the extract becomes worse, and the generation of heated odor becomes prominent due to heat sterilization and long-term storage. If the extraction temperature is too low, the pyrazine component in the roasted tea is not sufficiently extracted, and this effect may not be obtained. The extraction time is preferably 1 to 30 minutes, more preferably 2 to 10 minutes. The weight ratio of water to be extracted with respect to tea leaves is preferably 5 to 500, and more preferably 5 to 100.
本発明においては、このようにして得られた茶葉抽出液に、ケルセチン配糖体を添加する。 In the present invention, quercetin glycoside is added to the tea leaf extract thus obtained.
本発明において、「ケルセチン配糖体」というときは、特に記載した場合を除き、フラボノイドの一種であるケルセチン(クエルセチンとも呼ばれる)の配糖体を指し、これは下式で表される。 In the present invention, “quercetin glycoside” refers to a glycoside of quercetin (also referred to as quercetin), which is a kind of flavonoid, unless otherwise specified, and is represented by the following formula.
(式中、(X)nは、糖鎖を表し、nは、1以上の整数である。)
ここで、ケルセチンにグリコシド結合するXで表される糖鎖を構成する糖は、例えば、グルコース、ラムノース、ガラクトース、グルクロン酸であり、好ましくはグルコース、ラムノースである。また、nは1以上であれば、特に制限されないが、好ましくは1〜16、さらに好ましくは1〜8である。nが2以上であるとき、X部分は1種類の糖鎖からなっていてもよく、複数の糖鎖からなっていてもよい。
(In the formula, (X) n represents a sugar chain, and n is an integer of 1 or more.)
Here, the saccharide | sugar which comprises the sugar chain represented by X which glycoside-bonds to quercetin is glucose, a rhamnose, galactose, and glucuronic acid, for example, Preferably they are glucose and a rhamnose. Further, n is not particularly limited as long as it is 1 or more, but is preferably 1 to 16, and more preferably 1 to 8. When n is 2 or more, the X moiety may consist of one type of sugar chain or a plurality of sugar chains.
本明細書においては、ケルセチンにグルコースが一つ配されたものを、QG1、2つ配されたものをQG2、3つ配されたものをQG3(以下、グルコースが一つ増すごとに、QG4、QG5、QG6・・・)と表すことがある。 In the present specification, one glucose is arranged in quercetin, QG1, two arranged QG2, three arranged QG3 (hereinafter, every time glucose increases, QG4, QG5, QG6 ...).
本発明のケルセチン配糖体は、既存のケルセチン配糖体を、酵素などで処理して糖転移させたものも含む。 The quercetin glycoside of the present invention includes a product obtained by treating an existing quercetin glycoside with an enzyme or the like to cause sugar transfer.
本発明でいうケルセチン配糖体は、具体的には、ルチン、酵素処理ルチン、クエルシトリン、イソクエルシトリンを含む。 The quercetin glycoside referred to in the present invention specifically includes rutin, enzyme-treated rutin, quercitrin, and isoquercitrin.
ルチンは、下式で表される化合物である。 Rutin is a compound represented by the following formula.
ルチンは、ルトサイド又はケルセチン−3−ルチノシドと称されることもある。 Rutin is sometimes referred to as lutoside or quercetin-3-rutinoside.
酵素処理ルチンとは、ルチン又はその類縁体を酵素処理したものを成分とするものをいう。酵素処理ルチンは、酵素処理イソクエルシトリン又は糖転移ルチンと称されることもある。 Enzyme-treated rutin refers to an ingredient obtained by enzymatic treatment of rutin or an analog thereof. Enzyme-treated rutin is sometimes referred to as enzyme-treated isoquercitrin or sugar transfer rutin.
本発明においては、ケルセチン配糖体に包含される一の化合物を、単独で用いてもよいし、複数の化合物の混合を用いてもよい。 In the present invention, one compound included in the quercetin glycoside may be used alone, or a mixture of a plurality of compounds may be used.
本発明で使用するケルセチン配糖体は、その由来、製法については特に制限はない。例えば、ケルセチンを多く含む植物として、ケッパー、リンゴ、茶、タマネギ、ブドウ、ブロッコリー、モロヘイヤ、ラズベリー、コケモモ、クランベリー、オプンティア、葉菜類、柑橘類などが知られており、これらの植物からケルセチン配糖体を得ることができる。 The quercetin glycoside used in the present invention is not particularly limited in its origin and production method. For example, capers, apples, tea, onions, grapes, broccoli, moroheiya, raspberries, bilberries, cranberries, optia, leaf vegetables, citrus fruits, etc. are known as plants rich in quercetin, and quercetin glycosides are derived from these plants. Can be obtained.
本発明の特に好ましい態様においては、ケルセチン配糖体として、ルチンの酵素処理物(以下、酵素処理ルチン)を使用する。 In a particularly preferred embodiment of the present invention, an enzyme-treated product of rutin (hereinafter, enzyme-treated rutin) is used as the quercetin glycoside.
酵素処理ルチンの特に好ましい例は、ケルセチン配糖体を酵素処理してラムノース糖鎖部分を除去したイソクエルシトリン、イソクエルシトリンを糖転移酵素で処理してグルコース1〜7個からなる糖鎖が結合したもの、及びその混合物を主成分とするものである。 Particularly preferred examples of the enzyme-treated rutin include isoquercitrin obtained by enzymatically treating quercetin glycoside and removing the rhamnose sugar chain portion, and a sugar chain comprising 1 to 7 glucoses by treating isoquercitrin with a glycosyltransferase. The main component is a combination or a mixture thereof.
イソクエルシトリンは、例えば、WO2005/030975に記載されている方法、すなわち、ルチンを、特定の可食性成分の存在下でナリンギナーゼで処理する方法によって製造することができる。さらに、WO2005/030975に記載されているように、イソクエルシトリンを糖転移酵素で処理することにより、α-グリコシルイソクエルシトリンを得ることができる。 Isoquercitrin can be produced, for example, by the method described in WO2005 / 030975, that is, by treating rutin with naringinase in the presence of a specific edible component. Furthermore, as described in WO2005 / 030975, α-glycosylisoquercitrin can be obtained by treating isoquercitrin with a glycosyltransferase.
一般に、ルチンには抗酸化作用があることが知られていたが、水に難溶性であるため使用用途が限られていた。しかしながら酵素処理ルチンは糖転移により水溶性が向上しているため飲料に好適に使用できる。酵素処理ルチンは強力な抗酸化活性のほか、血小板の凝集抑制および接着抑制作用、血管拡張作用、抗癌作用など、多彩な生理機能を持つことが知られており、炎症の改善や血液循環促進などの効果を目的とした健康食品に利用されている。酵素処理ルチンは、例えば、エンジュ、ソバなどの抽出物を糖転移酵素で処理して得ることができる。 In general, rutin is known to have an antioxidant effect, but its use is limited because it is sparingly soluble in water. However, enzyme-treated rutin can be suitably used in beverages because of its improved water solubility due to sugar transfer. Enzyme-treated rutin is known to have a variety of physiological functions, including potent antioxidant activity, platelet aggregation and adhesion inhibition, vasodilation, and anticancer activity, improving inflammation and promoting blood circulation It is used in health foods for the purpose of such effects. The enzyme-treated rutin can be obtained, for example, by treating an extract such as Enju or buckwheat with a glycosyltransferase.
本発明の飲料におけるケルセチンの配合量は、20〜5000ppm、好ましくは100〜2500ppm、さらに好ましくは200〜1500ppm、最も好ましくは100〜500ppmである。なお、本明細書中、ppmは重量比(mg/kg)を示す。別の観点からは、ケルセチンはまた、350〜500ml容量の容器詰め飲料1本当たり、10〜1800mg、好ましくは50〜900mg、より好ましくは100〜500mgとすることができる。なお、本発明で飲料中のケルセチンの配合量をいうときは、特に記載した場合を除き、ケルセチン配糖体の配合量を合計したものをQG1として換算して得られる量を指す。 The blending amount of quercetin in the beverage of the present invention is 20 to 5000 ppm, preferably 100 to 2500 ppm, more preferably 200 to 1500 ppm, and most preferably 100 to 500 ppm. In the present specification, ppm indicates a weight ratio (mg / kg). From another point of view, quercetin can also be 10-1800 mg, preferably 50-900 mg, more preferably 100-500 mg per bottled beverage of 350-500 ml capacity. In addition, when referring to the blending amount of quercetin in the beverage in the present invention, it refers to the amount obtained by converting the sum of the blending amounts of quercetin glycoside as QG1, unless otherwise specified.
ケルセチン配糖体量の測定は、当業者にはよく知られた定法により、行うことができる。本明細書中おけるケルセチン配糖体とは、特に記載した場合を除き、ケルセチン配糖体の主要な構成成分であるQG1〜QG7をいい、ケルセチン配糖体量は下記の方法により求めてもよい:すなわち、標準物質としてQuercetin 3-O- glucoside(QG1)を用い、HPLCを用いて、紫外部吸光度350 nmにおける面積と標準物質濃度により検量線を作成する。ケルセチン配糖体は、小腸でケルセチンに加水分解されることから、QG1からQG7は生理活性的に同等であると考えられ、またケルセチンの3位配糖体は糖鎖の長さに関らず、すべて350nmに極大吸収を持ち、その吸光度はアグリコン部分であるケルセチンに依拠する。したがって、分子量は異なるが、モル吸光度ではQG1〜QG7は等しくなると考えられ、QG1換算でケルセチン配糖体量を定量する。具体的には、分析試料を、標準物質と同一条件でHPLCに供し、得られたチャートにおいて、標準物質の溶出保持時間と一致するピークを特定する。そして、QG1のピークより前に検出されるケルセチン配糖体QG2〜QG7のピークを特定し(もしあれば)、各々のピーク面積の総計から、標準物質を用いて作成した検量線を用いて、分析試料中のケルセチン配糖体含量を算出する。 The amount of quercetin glycoside can be measured by an ordinary method well known to those skilled in the art. Unless otherwise specified, quercetin glycoside in the present specification refers to QG1 to QG7, which are the main components of quercetin glycoside, and the amount of quercetin glycoside may be determined by the following method. : In other words, using Quercetin 3-O-glucoside (QG1) as a standard substance and using HPLC, create a calibration curve based on the area at an ultraviolet absorbance of 350 nm and the standard substance concentration. Quercetin glycosides are hydrolyzed to quercetin in the small intestine, so QG1 to QG7 are considered to be physiologically equivalent, and quercetin 3-position glycosides do not depend on the length of the sugar chain. , All have a maximum absorption at 350 nm, and its absorbance depends on quercetin, which is an aglycon moiety. Therefore, although molecular weights are different, QG1 to QG7 are considered to be equal in terms of molar absorbance, and the amount of quercetin glycoside is quantified in terms of QG1. Specifically, the analytical sample is subjected to HPLC under the same conditions as the standard substance, and a peak that matches the elution retention time of the standard substance is specified in the obtained chart. Then, the peaks of quercetin glycosides QG2 to QG7 detected before the peak of QG1 are identified (if any), and from the total of each peak area, using a calibration curve created using a standard substance, The quercetin glycoside content in the analysis sample is calculated.
本発明においては、茶葉抽出液にケルセチン配糖体を添加して得られた液を、加熱殺菌する。容器詰工程も行うが、それは加熱殺菌の前であっても後であってもよい。典型的には、容器詰の後に加熱殺菌を行う。さらに、必要に応じて、適切なタイミングで、飲料に対して通常行われる工程を行ってもよい。例えば、飲料のpHを調節してもよいし、追加的な成分を添加してもよい。 In this invention, the liquid obtained by adding a quercetin glycoside to a tea leaf extract is heat-sterilized. A container filling step is also performed, which may be before or after heat sterilization. Typically, heat sterilization is performed after container filling. Furthermore, you may perform the process normally performed with respect to a drink at an appropriate timing as needed. For example, the pH of the beverage may be adjusted or additional ingredients may be added.
本発明の容器詰茶飲料のpHは特に限定されるものではないが、ケルセチン配糖体の安定性の観点からはpH6.0以下であることが好ましく、pH5.8以下であることがさらに好ましい。香味の観点からは、いずれの場合もpH5.6以上であることが好ましく、pH5.8以上であることがさらに好まし。総合的には、pH5.8〜6.0であることが、より好ましい。 Although the pH of the packaged tea beverage of the present invention is not particularly limited, it is preferably pH 6.0 or less, more preferably pH 5.8 or less from the viewpoint of the stability of the quercetin glycoside. . From the viewpoint of flavor, in any case, the pH is preferably 5.6 or more, and more preferably pH 5.8 or more. Overall, it is more preferable that the pH is 5.8 to 6.0.
飲料のpHを調整する方法としては、飲料に酸やアルカリを添加すること、イオン交換樹脂へ通液させることが挙げられる。用いられる酸成分としては、例えば、有機酸としてはクエン酸、乳酸、酒石酸、コハク酸、リンゴ酸、アスコルビン酸など、無機酸としては塩酸、リン酸などが挙げられる。アルカリ成分としては水酸化ナトリウム、水酸化カリウム、重曹などが挙げられる。 Examples of the method for adjusting the pH of the beverage include adding an acid or alkali to the beverage and passing the solution through an ion exchange resin. Examples of the acid component to be used include citric acid, lactic acid, tartaric acid, succinic acid, malic acid, and ascorbic acid as organic acids, and hydrochloric acid and phosphoric acid as inorganic acids. Examples of the alkali component include sodium hydroxide, potassium hydroxide and sodium bicarbonate.
本発明の飲料は、上述した成分の他、乳化剤、酸化防止剤等の、飲料として許容される添加物を配合してもよい。 In addition to the components described above, the beverage of the present invention may contain additives acceptable as beverages such as emulsifiers and antioxidants.
本発明の飲料は、殺菌処理や長期保存により発生する、ケルセチン配糖体に起因する不快な加熱臭が抑制される。したがって、本発明の飲料は、容器詰飲料として好適に提供されるものである。加熱殺菌の方法としては、公知の方法を採用することができ、例えば、レトルト殺菌法、高温短時間殺菌法(HTST法)、超高温殺菌法(UHT法)などを好適に行うことができる。容器詰茶飲料の容器に応じて加熱殺菌法を適宜選択することもでき、例えば、PETボトルを飲料容器として用いる場合などはUHT殺菌が好適である。また、加熱装置や加熱方式にも特に制限はなく、例えば、直接水蒸気を吹き込むスチームインジェクション式や飲料を水蒸気中に噴射して加熱するスチームインフュージョン式などの直接加熱方式、プレートやチューブなど表面熱交換器を用いる間接加熱方式など公知の方法で行うことができる。加熱殺菌の温度は目的を達することができれば特に制限されないが、90℃以上であることが好ましい。 In the beverage of the present invention, an unpleasant heated odor caused by quercetin glycoside, which is generated by sterilization treatment or long-term storage, is suppressed. Therefore, the beverage of the present invention is suitably provided as a packaged beverage. As a heat sterilization method, a known method can be employed. For example, a retort sterilization method, a high temperature short time sterilization method (HTST method), an ultra high temperature sterilization method (UHT method), or the like can be suitably performed. A heat sterilization method can also be appropriately selected according to the container of the packaged tea beverage. For example, UHT sterilization is preferable when a PET bottle is used as a beverage container. Also, there is no particular limitation on the heating device and heating method, for example, a direct injection method such as a steam injection method in which water vapor is directly blown or a steam infusion method in which a beverage is injected into water vapor, a surface heat such as a plate or a tube. It can be performed by a known method such as an indirect heating method using an exchanger. The temperature of the heat sterilization is not particularly limited as long as the purpose can be achieved, but it is preferably 90 ° C. or higher.
以下、本発明を実施例に基づいて、より具体的に説明する。なお本発明はこれらの実施例に限定されるものではない。 Hereinafter, the present invention will be described more specifically based on examples. The present invention is not limited to these examples.
なお、本実施例においては、ケルセチン配糖体量の測定は、下記の方法で行った。 In this example, the amount of quercetin glycoside was measured by the following method.
1. 分析方法(機器および試薬、操作方法)
1-1.試薬
・アセトニトリル:高速液体クロマトグラフ用 純度99.8%(ナカライテスク株式会社製)
・水:高速液体クロマトグラフ用 不純物0.001%以下(ナカライテスク株式会社製)
・トリフルオロ酢酸:純度99%(ナカライテスク株式会社製)
・イソクエルシトリン(Quercetin 3-O- glucoside: 以下QG1とする): SSX1327S、純度93.8% (フナコシ株式会社製)
・エタノール:高速液体クロマトグラフ用 純度99.8%(ナカライテスク株式会社製)
・ジメチルスルホキシド(dimethyl sulfoxide: 以下DMSOとする):純度99.0%(ナカライテスク株式会社製)。
1. Analysis method (equipment and reagents, operation method)
1-1. Reagent / Acetonitrile: High-performance liquid chromatograph purity 99.8% (manufactured by Nacalai Tesque)
・ Water: Impurity for high performance liquid chromatograph 0.001% or less (manufactured by Nacalai Tesque)
・ Trifluoroacetic acid: 99% purity (manufactured by Nacalai Tesque)
・ Isoquercitrin (Quercetin 3-O-glucoside: QG1): SSX1327S, purity 93.8% (Funakoshi Co., Ltd.)
・ Ethanol: 99.8% purity for high performance liquid chromatography (manufactured by Nacalai Tesque)
Dimethyl sulfoxide (hereinafter referred to as DMSO): purity 99.0% (manufactured by Nacalai Tesque).
1-2.分析機器
高速液体クロマトグラフ(以下HPLCとする)
ポンプ:LC-10ADvp
検出器: SPD-M10Avp検出器
解析ソフト:Class LCsolution (以上、株式会社島津製作所)
1-3.分析試料の調製
・当該食品の原液を20%エタノール/水で5倍希釈し、0.45 μmフィルター(マイレクスLH-4:ミリポア社製)でろ過したものを分析試料としてHPLCに供する。
1-2. Analytical instrument high performance liquid chromatograph (hereinafter referred to as HPLC)
Pump: LC-10ADvp
Detector: SPD-M10Avp detector
Analysis software: Class LCsolution (Shimadzu Corporation)
1-3. Preparation of analysis sample ・ The stock solution of the food is diluted 5-fold with 20% ethanol / water and filtered through a 0.45 μm filter (Mirex LH-4: manufactured by Millipore) for HPLC.
1-4.検量線の作成
標準物質であるQuercetin 3-O- glucoside (フナコシ株式会社製:SSX 1327S、純度93.8%)を1.0 mg正確に秤量し、5 mlメスフラスコ中で0.5 mlのジメチルスルホキシド(DMSO:ナカライテスク株式会社製 純度99.0%)に溶解し、20%エタノール(ナカライテスク株式会社製 純度99.8% 高速液体クロマトグラフ用特製試薬)/水により5 mlにフィルアップする。この200 μg/mlの溶液を20%エタノール/水で順次希釈し、10、25、50、100 μg/mlの溶液を作成する。各濃度の溶液を10 μl、 HPLCに供する。このときに検出されるピークの溶出保持時間は約14.5分である。このときの紫外部吸光度350 nmにおける面積と濃度により検量線を作成する。
1-4. Preparation of calibration curve 1.0 mg of Quercetin 3-O-glucoside (Funakoshi Co., Ltd .: SSX 1327S, purity 93.8%), the standard substance, was accurately weighed and 0.5 ml of dimethyl sulfoxide (DMSO: Nacalai in a 5 ml volumetric flask) Dissolve in Tesque Co., Ltd. (purity 99.0%), and fill up to 5 ml with 20% ethanol (Nacalai Tesque Co., Ltd., purity 99.8% Special reagent for high performance liquid chromatography) / water. This 200 μg / ml solution is diluted sequentially with 20% ethanol / water to make 10, 25, 50, and 100 μg / ml solutions. 10 μl of each concentration solution is subjected to HPLC. The elution retention time of the peak detected at this time is about 14.5 minutes. At this time, a calibration curve is prepared based on the area and concentration at an ultraviolet absorbance of 350 nm.
原点を通る近似直線を計算し、これを用いてQG1からQG7までの濃度を算出し、合算した値に標準物質の純度(93.8%)をかけることで、ケルセチン配糖体量を算出する。 Calculate an approximate straight line passing through the origin, calculate the concentration from QG1 to QG7 using this, and calculate the amount of quercetin glycoside by multiplying the sum by the purity of the standard substance (93.8%).
1-5.試験操作
・定性試験:分析試料を標準品と同一条件下でHPLC分析を行い、QG1標準品の溶出保持時間と一致するピークをQG1とする。QG1はケルセチンにグルコースが1個結合したケルセチン配糖体である。
・定量試験: QG1のピークより前に検出される6つのピークは、QG1にさらにグルコース結合したケルセチンの配糖体である。HPLC分析では、QG1およびQ G1にさらにグルコースが1〜6個結合した化合物が検出可能であり、これらQG1〜QG7について、標準品が入手可能なQG1を指標成分と設定し、QG1換算での量を算出する。ケルセチン配糖体の7つの溶出ピークについてのピーク面積を測定し、QG1標準品のピーク面積に基づいて作成した検量線から分析試料中のケルセチン配糖体含量を算出する。
1-5. Test procedure and qualitative test: Analyze the analysis sample under the same conditions as the standard, and set the peak that matches the elution retention time of the QG1 standard to QG1. QG1 is a quercetin glycoside in which one glucose is bound to quercetin.
Quantitative test: The six peaks detected before the QG1 peak are glycosides of quercetin further glucose-bound to QG1. In HPLC analysis, compounds in which 1 to 6 glucoses are further bound to QG1 and QG1 can be detected.For these QG1 to QG7, QG1 available as a standard product is set as an indicator component, and the amount in terms of QG1 Is calculated. The peak areas of the seven elution peaks of quercetin glycoside are measured, and the quercetin glycoside content in the analysis sample is calculated from a calibration curve created based on the peak area of the QG1 standard product.
イソクエルシトリン(QG1)は、ケルセチンの3位に1分子のグルコースがβ結合した化合物である。QG2〜QG7はQG1にさらに0 〜6個のグルコースがα-1,4結合した化合物群で、QG1およびQG2〜QG7の7成分の合計を、ケルセチン配糖体量とする。 Isoquercitrin (QG1) is a compound in which one molecule of glucose is β-bonded to the 3-position of quercetin. QG2 to QG7 are compound groups in which 0 to 6 glucoses are further α-1,4 linked to QG1, and the total of the seven components QG1 and QG2 to QG7 is defined as the amount of quercetin glycoside.
ケルセチンの3位配糖体は糖鎖の長さに関らず、すべて350nmに極大吸収を持ち、その吸光度はアグリコン部分であるケルセチンが寄与する。従って、分子量は異なるが、モル吸光度ではQG1からQG7は等しくなると考え、QG1換算でケルセチン配糖体量を定量することとした。 Regardless of the length of the sugar chain, quercetin 3-position glycosides all have a maximum absorption at 350 nm, and the absorbance is contributed by quercetin, which is an aglycon moiety. Therefore, although the molecular weight is different, QG1 to QG7 are considered to be equal in terms of molar absorbance, and the amount of quercetin glycoside was determined in terms of QG1.
表1に従い茶葉を秤量し、約70℃の純水2.2Lにより5分間抽出し、ろ過し、各種緑茶抽出液を得た。得られた緑茶抽出液に、サンエミックP15(イソクエルシトリン配糖体含有製剤)を30gを加え、加水し、7.5Lの各種緑茶飲料を得た。その際、重曹でpH5.9に調整した。得られた各種緑茶飲料を、UHT殺菌処理した後、500mlのPET容器に各2本ずつ充填した。1本は製造直後のケルセチン配糖体由来の粉っぽさ、及びエグ味について官能評価を行い、もう1本は55℃5日間の加速劣化試験後に、同様の官能評価を行った。官能評価は訓練された5名のパネラーにより下に示す3段階評価行い、最も点数の多かった評価を表1に記した。なお、表1中の「飲料中のケルセチン配糖体量」は、上述の方法にて算出したQG1換算値である。 According to Table 1, tea leaves were weighed, extracted with 2.2 L of pure water at about 70 ° C. for 5 minutes, and filtered to obtain various green tea extracts. To the obtained green tea extract, 30 g of Sanemic P15 (isoquercitrin glycoside-containing preparation) was added and hydrated to obtain 7.5 L of various green tea beverages. At that time, the pH was adjusted to 5.9 with sodium bicarbonate. The various green tea beverages obtained were UHT sterilized and then filled into 500 ml PET containers. One was sensory-evaluated about the powderyness derived from the quercetin glycoside immediately after manufacture, and the taste, and the other was subjected to the same sensory evaluation after an accelerated deterioration test at 55 ° C. for 5 days. The sensory evaluation was performed by the five trained panelists as shown in the following three-step evaluation. The evaluation with the highest score is shown in Table 1. In addition, “the amount of quercetin glycoside in the beverage” in Table 1 is a QG1 equivalent value calculated by the above-described method.
粉っぽさ
○(粉っぽさを感じない)
△(粉っぽさを少し感じるが、許容できる)
×(粉っぽさが強く、許容できない)
エグ味
○(エグ味を感じない)
△(エグ味を少し感じるが、許容できる)
×(エグ味が強く、許容できない)
Powdery ○ (I do not feel powdery)
△ (I feel a little powdery but it is acceptable)
× (Powder is strong and unacceptable)
Egg taste ○ (I don't feel the taste)
△ (I feel a little bit of taste, but it ’s acceptable)
× (strong taste, unacceptable)
本結果より、焙じ茶葉を含む茶葉を抽出して得られた茶葉抽出液を用いると、ケルセチン配糖体に由来する粉っぽさ、及び加熱により生じるエグ味が低減されることがわかった。 From these results, it was found that when a tea leaf extract obtained by extracting tea leaves containing roasted tea leaves was used, the powderiness derived from quercetin glycoside and the taste produced by heating were reduced.
Claims (4)
(i)煎茶、番茶、または茎茶を180℃以上で焙煎して得られた焙じ茶葉から選択される1種以上と、煎茶、深蒸煎茶、玉露、かぶせ茶、番茶、玉緑茶、芽茶、茎茶、および棒茶からなる群から選択される1種以上の、焙じ茶葉を除く緑茶葉とを抽出して、茶葉抽出液を得る工程、
(ii)当該茶葉抽出液に前記ケルセチン配糖体を添加する工程、ここで、前記ケルセチン配糖体は、以下の構造:
(式中、(X)nは、糖鎖を表し、nは、1以上の整数である。)
を有し、および
(iii)工程(ii)において得られた液を加熱殺菌する工程。 A process for producing a green tea beverage containing a quercetin glycoside-containing container containing 100 to 500 ppm of quercetin glycoside , including the steps (i) to (iii):
(i) at least one selected from roasted tea leaves obtained by roasting sencha, bancha or stem tea at 180 ° C. or higher, sencha, deep steamed sencha, gyokuro, kabusecha, bancha, tama green tea, bud tea Extracting one or more green tea leaves excluding roasted tea leaves selected from the group consisting of stalk tea and stick tea to obtain a tea leaf extract,
(ii) adding the quercetin glycosides to the extract of tea leaves, where the quercetin glycoside has the following structure:
(In the formula, (X) n represents a sugar chain, and n is an integer of 1 or more.)
And
(iii) A step of heat sterilizing the liquid obtained in step (ii).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013205891A JP6250353B2 (en) | 2013-09-30 | 2013-09-30 | Containerized green tea beverage containing quercetin glycoside |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013205891A JP6250353B2 (en) | 2013-09-30 | 2013-09-30 | Containerized green tea beverage containing quercetin glycoside |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015065957A JP2015065957A (en) | 2015-04-13 |
JP6250353B2 true JP6250353B2 (en) | 2017-12-20 |
Family
ID=52833419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013205891A Active JP6250353B2 (en) | 2013-09-30 | 2013-09-30 | Containerized green tea beverage containing quercetin glycoside |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6250353B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017029024A (en) * | 2015-07-30 | 2017-02-09 | サントリー食品インターナショナル株式会社 | Enzyme-treated isoquercitrin containing container-packed beverage |
WO2018150571A1 (en) * | 2017-02-20 | 2018-08-23 | 花王株式会社 | Tea beverage |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4313961B2 (en) * | 2000-06-02 | 2009-08-12 | タカラバイオ株式会社 | Food, beverage or seasoning |
JP2005143467A (en) * | 2003-11-20 | 2005-06-09 | Kiyomitsu Kawasaki | Green tea flavored composition |
JP4015631B2 (en) * | 2004-02-19 | 2007-11-28 | 株式会社 伊藤園 | Method for producing containerized green tea beverage |
JP5081388B2 (en) * | 2006-02-08 | 2012-11-28 | 池田食研株式会社 | Method for producing quercetin-containing composition |
JP5215911B2 (en) * | 2009-03-02 | 2013-06-19 | 花王株式会社 | Tea drink |
JP5436895B2 (en) * | 2009-03-13 | 2014-03-05 | サントリーホールディングス株式会社 | Oral formulation containing water-extracted chondroitin and milk flavor |
CN102630779B (en) * | 2011-02-14 | 2015-07-22 | 三得利食品饮料株式会社 | Container-bottled drink for matching with quercetin glycoside |
JPWO2012111795A1 (en) * | 2011-02-18 | 2014-07-07 | 有限会社植物育種研究所 | Lifestyle-related disease-improving agent containing water extract of colored onion |
JP2013110989A (en) * | 2011-11-28 | 2013-06-10 | Sanei Gen Ffi Inc | Catechin-rich beverage |
-
2013
- 2013-09-30 JP JP2013205891A patent/JP6250353B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2015065957A (en) | 2015-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6463312B2 (en) | Bottled beverage containing quercetin glycoside | |
RU2471384C1 (en) | Beverage composition and monatin degradation reduction method | |
JP6257862B1 (en) | Stevia-containing beverage | |
JP2007117087A (en) | Black-tea beverage | |
JP6400298B2 (en) | Coffee drink | |
JP6250353B2 (en) | Containerized green tea beverage containing quercetin glycoside | |
JP2016189768A (en) | Beverage or food product, flavor composition, and method for suppressing generation of deterioration odor | |
JP6429749B2 (en) | Beverage containing enzyme-treated isoquercitrin | |
JP2005245351A (en) | Acidic beverage | |
JP6310625B1 (en) | Beverages containing tiliroside and chlorogenic acids | |
JP2016010401A (en) | Beverage | |
AU2016364469B2 (en) | Beverage containing hydroxytyrosol | |
JP2015065943A (en) | Quercetin glycoside beverage having color stability | |
WO2017094654A1 (en) | Beverage containing hydroxytyrosol | |
JP6896436B2 (en) | Beverage containing hesperidin in a container with suppressed offensive odor of hesperidin | |
JP2015091221A (en) | Tea beverage containing quercetin glycoside | |
WO2016157984A1 (en) | Beverage or food, fragrance composition, and method for preventing formation of degradation odor | |
JP6544850B2 (en) | Container-packed tea beverage with reduced bitter taste and reduced generation | |
JP5621010B2 (en) | HESPERIDINE-CONTAINING BEVERAGE AND PROCESS FOR PRODUCING THE SAME, AND METHOD OF PREVENTING FLAME DECISION OF HESPERIDINE-CONTAINING BEVERAGE | |
JP7361476B2 (en) | Packaged hesperidin-containing beverage with suppressed off-flavor and taste of hesperidin | |
JP6445850B2 (en) | Enzyme-treated isoquercitrin-containing beverage | |
JP6629581B2 (en) | Hydroxytyrosol-containing tea beverage | |
JP2019136008A (en) | Artemisia absinthium extract | |
JP5561810B1 (en) | Beverage | |
JP2017029024A (en) | Enzyme-treated isoquercitrin containing container-packed beverage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160404 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170214 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170215 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20170406 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170614 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20170904 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20171024 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20171122 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6250353 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |